Transcriptomic characterization of renal cell carcinoma patients with progressive disease despite low initial risk of progression

by S. Nakken, Ø. Eikrem, H-P. Marti, C. Beisland, A. Scherer, V. Beisvag, A. Flatberg, P. Strauss
Published 2020-07-01

Serum levels of the IL-33 decoy receptor soluble ST2; a possible prognostic marker in clear-cell renal cell carcinoma

by H.H. Aarstad, G. Gudbrandsdottir, K.M. Hjelle, T.H.A. Tvedt, Ø. Bruserud, L. Bostad, H.J. Aarstad, C. Beisland
Published 2020-07-01

Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castrati...

by L.C.V. Thomsen, A. Honoré, B. Almås, L.A.R. Reisæter, K. Førde, E.K. Kristoffersen, S.H. Kaada, G.K. Melve, S.I. Helle, G. Kvalheim, W. Azeem, J.R. Olsen, O.J. Halvorsen, L.A. Akslen, D. Bahn, K. Pantel, S. Riethdorf, H. Ragde, B.T. Gjertsen, A.M. Øyan, K.H. Kalland, C. Beisland
Published 2020-07-01